Delayed graft function and rejection are risk factors for cytomegalovirus breakthrough infection in kidney transplant recipients
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference14 articles.
1. Valganciclovir solid organ transplant study group. efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients;Paya;Am. J. Transplant.,2004
2. Valganciclovir solid organ transplant study group. Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients;Freeman;Transplantation,2004
3. Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study;Humar;Transplantation,2010
4. Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety;van den Hoogen;Am. J. Transplant.,2015
5. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International valacyclovir cytomegalovirus prophylaxis transplantation study group;Lowance;New Engl. J. Med.,1999
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Challenges for the improvement of valganciclovir prophylaxis in solid organ transplantation and the possible role of therapeutic drug monitoring in adults;British Journal of Clinical Pharmacology;2024-06-18
2. Kidney transplantation: the recipient;Living Donor Organ Transplantation;2024
3. Delayed Graft Function Among Kidney Transplant Recipients Is Associated With an Increased Risk of Urinary Tract Infection and BK Viremia;Transplantation Direct;2023-08-28
4. The effect of late‐onset CMV infection on the outcome of renal allograft considering initial graft function;Transplant Infectious Disease;2023-05-29
5. Discordance in cytomegalovirus viremia in kidney recipients from the same donor is associated with the worst outcomes;Clinical Transplantation;2023-03-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3